Macrophage and Cancer Cell Cross-talk via CCR2 and CX3CR1 Is a Fundamental Mechanism Driving Lung Cancer
Anja Schmall(Max Planck Institute for Heart and Lung Research), Rajkumar Savai(Goethe University Frankfurt), Werner Seeger(Justus-Liebig-Universität Gießen), Susanne Herold(Justus-Liebig-Universität Gießen), Andreas Weigert(Goethe University Frankfurt), Natasha Vipotnik(Max Planck Institute for Heart and Lung Research), Soni Savai Pullamsetti(Justus-Liebig-Universität Gießen), Astrid Wietelmann(Max Planck Institute for Heart and Lung Research), Friedrich Grimminger(Justus-Liebig-Universität Gießen), Hamza M. Al-tamari(Max Planck Institute for Heart and Lung Research), Marian Kampschulte(Justus-Liebig-Universität Gießen)
American Journal of Respiratory and Critical Care Medicine
December 23, 2014
Cited by 274
Related Papers
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k
Mechanisms of disease: pulmonary arterial hypertension
|Nature Reviews Cardiology|2011|784
Pulmonary hypertension in chronic lung disease and hypoxia
|European Respiratory Journal|2018|777